She received her A.B. from the Department of Molecular Biology at Princeton University and her M.D. from Jefferson Medical College in Philadelphia, PA before completing her training in internal medicine and hematology/oncology at Georgetown University Hospital. Dr. Liu is involved in clinical and translational research with a particular focus on developing new methods by which to detect breast cancer and on understanding the molecular mechanisms responsible for determining chemotherapy sensitivity vs. resistance. Her work is currently supported by the National Cancer Institute, the Department of Defense and industry-sponsored grants. Most importantly, Dr. Liu is firmly dedicated to the care and education of women with breast cancer and uses an individualized, multidisciplinary approach to patient management.